Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association

Mac Grory, Brian, Schrag, Matthew, Biousse, Valérie, Furie, Karen L., Gerhard-Herman, Marie, Lavin, Patrick J., Sobrin, Lucia, Tjoumakaris, Stavropoula I., Weyand, Cornelia M., Yaghi, Shadi, on behalf of the American Heart Association Stroke Council; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; and Council on Peripheral Vascular Disease·2021·Stroke

Abstract

Purpose: Central retinal artery occlusion (CRAO) is a form of acute ischemic stroke that causes severe visual loss and is a harbinger of further cerebrovascular and cardiovascular events. There is a paucity of scientific information on the appropriate management of CRAO, with most strategies based on observational literature and expert opinion. In this scientific statement, we critically appraise the literature on CRAO and provide a framework within which to consider acute treatment and secondary prevention. Methods: We performed a literature review of randomized controlled clinical trials, prospective and retrospective cohort studies, case-control studies, case reports, clinical guidelines, review articles, basic science articles, and editorials concerning the management of CRAO. We assembled a panel comprising experts in the fields of vascular neurology, neuro-ophthalmology, vitreo-retinal surgery, immunology, endovascular neurosurgery, and cardiology, and document sections were divided among the writing group members. Each member received an assignment to perform a literature review, synthesize the data, and offer considerations for practice. Multiple drafts were circulated among the group until consensus was achieved. Results: Acute CRAO is a medical emergency. Systems of care should evolve to prioritize early recognition and triage of CRAO to emergency medical attention. There is considerable variability in management patterns among practitioners, institutions, and subspecialty groups. The current literature suggests that treatment with intravenous tissue plasminogen activator may be effective. Patients should undergo urgent screening and treatment of vascular risk factors. There is a need for high-quality, randomized clinical trials in this field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/str.0000000000000366

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Metadata

Authors
Mac Grory, B., Schrag, M., Biousse, V., Furie, K. L., Gerhard-Herman, M., Lavin, P. J., Sobrin, L., Tjoumakaris, S. I., Weyand, C. M., Yaghi, S., & on behalf of the American Heart Association Stroke Council; Council on Arteriosclerosis, T. A. V. B. C. O. H. A. C. O. P. V. D.
Venue
Stroke
Published
2021-06
Volume
52
Issue
6
Pages
e282-e294
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W3134997650
Cited by
306
References
48
FWCI
27.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. https://app.cochat.ai/papers/10.1161/str.0000000000000366
The paper
Mac Grory, B., Schrag, M., Biousse, V., Furie, K. L., Gerhard-Herman, M., Lavin, P. J., Sobrin, L., Tjoumakaris, S. I., Weyand, C. M., Yaghi, S., & on behalf of the American Heart Association Stroke Council; Council on Arteriosclerosis, T. A. V. B. C. O. H. A. C. O. P. V. D. (2021). Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association. Stroke. https://doi.org/10.1161/str.0000000000000366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.